The burgeoning telehealth industry, lauded for its potential to democratize healthcare access, is facing intensified scrutiny as companies push the…
Read More
Rethinking Evidence Generation for Ultra-Rare Diseases
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
How Medvi Built a $1.8 Billion Telehealth Empire in Regulatory Blind Spots: A Deep Dive into AI, Compounding, and Fragmented Oversight
The rapid ascent of Medvi, a telehealth company projected to achieve a staggering $1.8 billion valuation this year, has thrust…
Read More
Sai Life Sciences Hosts Landmark Biotech Pitch Day 2026, Spotlighting Innovative Early-Stage Therapies and Fostering Strategic Collaborations
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Beyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity market
The pharmaceutical landscape is currently undergoing a seismic shift, largely driven by the unprecedented success of GLP-1 receptor agonists in…
Read More
Immuto Scientific Pioneers a Step Change in Protein Structure Throughput by Integrating AI and Mass Spectrometry
The landscape of drug discovery and development is undergoing a profound transformation, driven by an urgent need for speed, precision,…
Read More
How to tackle the unique pharmacokinetic properties of covalent drugs
The landscape of modern medicine has been profoundly shaped by therapeutic agents that form stable, enduring bonds with their biological…
Read More
Amazon Bio Discovery Accelerates Drug Development, Cuts MSK Antibody Design from a Year to Weeks
Amazon Web Services (AWS) has unveiled Amazon Bio Discovery, a groundbreaking application designed to dramatically accelerate the drug discovery process,…
Read More
Closing the information gap: ETH Zürich team integrates function and binding in one drug screening assay
A groundbreaking innovation from a collaborative team at ETH Zurich and Karolinska Institutet is poised to revolutionize early-stage drug discovery…
Read More
Insilico CEO Sees Potentially $2.75 Billion Collaboration as Fusing Lilly’s Clinical Excellence with Insilico’s End-to-End AI Engine
On March 29, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven drug discovery and development, announced a monumental drug discovery…
Read MoreYOU MAY HAVE MISSED
